PlainRecalls
FDA Devices Moderate Class II Terminated

VERIGENE Blood Culture Gram-Positive Nucleic Acid Kits (packaged as five-pack carriers) Product Usage: In vitro diagnostic test for the simultaneous detection and identification of potentially pathogenic gram-positive bacteria.

Reported: November 21, 2018 Initiated: September 14, 2018 #Z-0445-2019

Product Description

VERIGENE Blood Culture Gram-Positive Nucleic Acid Kits (packaged as five-pack carriers) Product Usage: In vitro diagnostic test for the simultaneous detection and identification of potentially pathogenic gram-positive bacteria.

Reason for Recall

Potential to lead to a false negative results.

Details

Recalling Firm
Luminex Corporation
Units Affected
12,700 trays
Distribution
Worldwide Distribution - US Nationwide in the states of United States - AZ, CA, CO, CT, DC, FL, GA,, IA, ID, IN, KA,, KS, KY, LA, MA, MD, MI, MN, MO, MS, NC, ND, NV, NJ, NY, OK,,OH, OR, PA, SC, TN, TX, UT, VT, WA, KS, and VA.. France
Location
Austin, TX

Frequently Asked Questions

What product was recalled?
VERIGENE Blood Culture Gram-Positive Nucleic Acid Kits (packaged as five-pack carriers) Product Usage: In vitro diagnostic test for the simultaneous detection and identification of potentially pathogenic gram-positive bacteria.. Recalled by Luminex Corporation. Units affected: 12,700 trays.
Why was this product recalled?
Potential to lead to a false negative results.
Which agency issued this recall?
This recall was issued by the FDA Devices on November 21, 2018. Severity: Moderate. Recall number: Z-0445-2019.